Arbutus Biopharma
$1.679876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (1.83%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ABUS and other stocks, options, ETFs, and crypto commission-free!
About ABUS
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.
Employees
80
Headquarters
Burnaby, British Columbia
Founded
2005
Market Cap
94.94M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
174.80K
High Today
$1.72
Low Today
$1.61
Open Price
$1.66
Volume
125.22K
52 Week High
$10.15
52 Week Low
$1.29
Collections
Price Paid on Robinhood
66% Lower
Right Now
52 Week Low
$2.72
Average Price Paid
$4.86
52 Week High
$12.60
ABUS Earnings
-$0.47
-$0.41
-$0.36
-$0.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 6, Pre-Market